AHRQ Health Care Innovations Exchange, 55214-55216 [07-4771]
Download as PDF
<![CDATA[
55214
Federal Register / Vol. 72, No. 188 / Friday, September 28, 2007 / Notices
either the United States or the FTC,
alleging any violation of the order.
The purpose of this analysis is to
facilitate public comment on the
proposed order. It is not intended to
constitute an official interpretation of
the proposed order or to modify in any
way its terms.
By direction of the Commission.
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
Donald S. Clark,
Secretary.
[FR Doc. E7–19159 Filed 9–27–07: 8:45 am]
Dated: September 24, 2007.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. E7–19297 Filed 9–27–07; 8:45 am]
Billing Code: 6750–01–S
BILLING CODE 4160–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
jlentini on PROD1PC65 with NOTICES
Sheet metal workers, physical plant
maintenance and associated support staff
(including all maintenance shop personnel),
and supervisory staff who were monitored or
should have been monitored for potential
internal radiation exposures associated with
the maintenance and renovation activities of
the thorium production areas in Wilhelm
Hall (a.k.a. the Metallurgy Building or ‘‘Old’’
Metallurgy Building) at the Ames Laboratory
from January 1, 1955, through December 31,
1970, for a number of work days aggregating
at least 250 work days or in combination
with work days within the parameters
established for one or more other classes of
employees in the Special Exposure Cohort.
This designation will become
effective on October 12, 2007, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for Occupational
Safety and Health; Designation of a
Class of Employees for Addition to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at the Ames Laboratory,
Ames, Iowa, as an addition to the
Special Exposure Cohort (SEC) under
the Energy Employees Occupational
Illness Compensation Program Act of
2000. On September 12, 2007, the
Secretary of HHS designated the
following class of employees as an
addition to the SEC:
17:12 Sep 27, 2007
Dated: September 24, 2007.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. E7–19243 Filed 9–27–07; 8:45 am]
BILLING CODE 4160–17–P
National Institute for Occupational
Safety and Health; Designation of a
Class of Employees for Addition to the
Special Exposure Cohort
VerDate Aug<31>2005
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
SUMMARY: The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at the Hanford Engineer
Works, Richland, Washington, as an
addition to the Special Exposure Cohort
(SEC) under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. On September 12,
2007, the Secretary of HHS designated
the following class of employees as an
addition to the SEC:
Employees of the Department of Energy
(DOE), its predecessor agencies, or DOE
contractors or subcontractors who were
monitored or should have been monitored for
internal radiological exposures while
working at the Hanford Engineer Works in:
the 300 Area fuel fabrication and research
facilities from October 1, 1943 through
August 31, 1946; the 200 Area plutonium
separation facilities from November 1, 1944
through August 31, 1946; or the 100 B, D, and
F reactor areas from September 1, 1944
through August 31, 1946; for a number of
work days aggregating at least 250 work days
or in combination with work days within the
parameters established for one or more other
classes of employees in the Special Exposure
Cohort.
This designation will become effective
on October 12, 2007, unless Congress
provides otherwise prior to the effective
date. After this effective date, HHS will
publish a notice in the Federal Register
reporting the addition of this class to the
SEC or the result of any provision by
Congress regarding the decision by HHS
to add the class to the SEC.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
AHRQ Health Care Innovations
Exchange
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Submission of
Innovations.
AGENCY:
SUMMARY: To support its objective of
accelerating the diffusion and adoption
of innovative health care delivery
changes, the Agency for Healthcare
Research and Quality (AHRQ) recently
launched version 1.0 of the AHRQ
Health Care Innovations Exchange
(HCIE) Web site, https://
www.innovations.ahrq.gov. The HCIE is
a new initiative designed to support
health care professionals in sharing and
adopting innovations that improve
health care quality. Version 1.0 of the
Web site is focused on stimulating
creativity and innovation and will serve
as a virtual place to which innovators
will be encouraged to submit their
innovations and experiences from
which potential adopters can begin
learning about the nuances of
implementation.
In Spring 2008, AHRQ will deploy
version 2.0 of its Health Care
Innovations Exchange site making
hundreds of profiles of health care
service innovations of varying degrees
of novelty and scientific rigor accessible
to the public. Version 2.0 will also offer
expert commentary; stories; tools;
lessons learned; ‘‘change packages’’—
sets of innovations implemented
simultaneously; expanded content on
implementation; and opportunities to
learn and network.
To build the database of innovations
profiles, AHRQ invites submissions of
E:\FR\FM\28SEN1.SGM
28SEN1
Federal Register / Vol. 72, No. 188 / Friday, September 28, 2007 / Notices
health service innovations to its Health
Care Innovations Exchange. The AHRQ
Health Care Innovations Exchange
database will cover the broad spectrum
of health care settings, systems, and
providers. Public health priority
diseases/conditions, priority
populations, and efforts to reduce
disparities in quality will be
highlighted.
The AHRQ Health Care Innovations
Exchange is seeking a broad range of
novel health care strategies, activities,
and tools. AHRQ invites participation in
its Health Care Innovations Exchange by
submitting descriptions of innovative
efforts to improve the delivery of health
care services.
DATES: There is no deadline for
submission. It is a continuous
submission and review process.
jlentini on PROD1PC65 with NOTICES
Special Incentive To Submit
AHRQ will provide early submitters
(those who submit by January 15, 2008)
and opportunity to preview and
comment on version 2.0 of the Health
Care Innovations Exchange Web site via
a secure mechanism. In this preview, an
opportunity will be given to browse and
search the innovations profiled up to
that point.
ADDRESSES: Submit to
info@innovations.ahrq.gov.
How To Submit
To submit a health care innovation for
possible posting, send a description of
the innovation that would include the
health care setting and patient
population it is our could be used for
and any results that have been
documented, to the Health Care
Innovations Exchange at
info@innovations.ahrq.gov. Please use
the words ‘‘Innovation Submission’’ in
the subject line. If you prefer, you can
fax information about your innovation
to 301–610–4950. You may also mail
information to Mary Nix, Agency for
Healthcare Research and Quality, Center
for Outcomes and Evidence, 540 Gaither
Road, Rockville, MD 20850. Detailed
information on submitting can be
obtained from the AHRQ Health Care
Innovations Exchange Web page titled
‘‘Share Your Innovations’’, https://
www.innovations.ahrq.gov/share/
share.aspx.
Supporting documents may be sent
with the submission. Once AHRQ has
reviewed your submission and
identified it as a priority item for
posting, AHRQ will contact the
submitter to discuss the details
regarding what will be included in
standardized postings. Copyright or
other intellectual property issues, if any,
will be addressed at that time.
VerDate Aug<31>2005
17:12 Sep 27, 2007
Jkt 211001
55215
If the innovation is accepted for
inclusion, AHRQ will develop a
detailed profile and send it to the
submitter to review for accuracy and
completeness. The innovation will then
be ready for publication in Version 2.0
of the Health Care Innovations Exchange
scheduled for public release in Spring
2008.
safety, and timeliness. The measurable
quality indicators do not have to come
from an established measure set, but
they must be clearly defined and
relevant to the quality issue the
innovation addresses. In addition, the
innovation must not contradict
established standards of evidence-based
care.
FOR FURTHER INFORMATION CONTACT:
There is reason to believe that the
innovation will be effective
Evidence that the innovation is likely
to achieve its goals must be provided.
Ideally, quantitative or qualitative
support for a link between the
innovation and improved performance
on the defined quality indicator should
be offered. However, if data are
unavailable, limited, or lacking
methodological rigor, the design or
theoretical foundation of the innovative
activity may serve as sufficient support.
Explore: https://www.innovations.
ahrq.gov; And/Or Contact: Mary P. Nix,
MS, MT(ASCP)SBB, Health Scientist
Administrator, Agency for Healthcare
Research and Quality, 540 Gaither Road,
Rockville, MD 20850, phone: 301–427–
1624, e-mail: Mary.Nix@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Inclusion Criteria
To be considered for inclusion, health
are innovations have to meet six criteria
with respect to the nature of the activity,
the level of documentation, and the
participation of the innovator. These are
minimum requirements. The ultimate
decision to publish a detailed profile of
an innovation (an Innovation Profile)
will depend on several factors,
including an evaluation by AHRQ,
AHRQ’s priorities (see below), and the
number of similar ideas in the Health
Care Innovations Exchange. Innovations
that do not qualify for an Innovation
Profile may qualify as Innovation Briefs
(short descriptions of intriguing
activities that either do not meet the
minimum requirements or are not
regarded as high priority) or Innovation
Attempts (descriptions of projects that
did not succeed as planned). Criteria to
be considered are:
The innovation is a patient care services
activity
The innovation does not have to
involve direct patient care or direct
contact with health care consumers.
However, it must have important
implications for the delivery of patient
care—whether preventative, emergent,
chronic, acute, rehabilitative, long-term,
or end-of-life. Innovations that are
devices, tools, technology, software,
curricula, policies, procedures, and
changes to the physical environment
will generally be excluded unless they
are tied to a specific and associated
change in the health care delivery
process when implemented.
The innovation intends to improve one
or more domains of health care quality
The innovation must be designed to
address one or more specific measurable
indicators of quality in one or more of
the following domains: effectiveness,
efficiency, equity, patient-centeredness,
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
The activity is truly innovative in a
given context
For the purposes of the Health Care
Innovation Exchange, innovations are
activities that are generally perceived as
new in a particular context or setting
relative to the usual care processes. In
addition to brand new ideas, this
includes activities adapted from other
industries to health care, transferred
from one health care setting or market
segment to another, drawn from settings
in other countries, or applied to a new
or different patient population. A
description of how the innovation
differs from what was regarded as
standard practice in the setting in which
it was implemented must be supplied.
Information about the innovation is
publicly available
Innovators must be willing to make
enough information freely available to
enable a user of the Health Care
Innovations Exchange to understand the
elements of the innovation and, if
desired, adopt the innovation. This
requirement does not exclude
innovations that incorporate
commercial products or other materials
for which there may be a fee or licensing
requirements. It is not necessary for all
information about the innovation to be
publicly available, but AHRQ will need
access to information with sufficient
detail to produce a full profile.
The innovator (or a representative) is
willing and able to participate in the
Health Care Innovations Exchange
A knowledgeable contact person must
be available as a resource for potential
adopters of the innovation for at least
one year. To minimize the burden on
innovators, the Health Care Innovations
E:\FR\FM\28SEN1.SGM
28SEN1
55216
Federal Register / Vol. 72, No. 188 / Friday, September 28, 2007 / Notices
Exchange staff will facilitate
communication among users and
developers of innovations. However, the
participation of the innovator is
essential to the ability of the Health Care
Innovations Exchange to foster and
promote the diffusion of innovations
through social learning, a central goal of
this program. The level of participation
can vary according to innovator interest
and schedules. Innovators will be
expected to respond to occasional
inquiries and to join a Health Care
Innovations Exchange community of
practice related to the innovator’s
particular innovation, so that ideas can
be shared in an organized instructional
fashion or setting.
AHRQ’s Priorities
• Specific populations. AHRQ is
interested in identifying innovations
that will help to reduce disparities in
health care and health status.
Populations of interest to AHRQ are
low-income groups, minority groups,
women, children, the elderly, and
individuals with special health care
needs.
• Potential for high impact. The
Health Care Innovations Exchange will
give publication or dissemination
priority to innovations that are likely to
have a significant effect on the overall
value of health care. Impact may be
defined in different ways, e.g., the
innovation may affect a broad
population, address a critical health
issue, or demonstrate large cost savings.
• Innovator interest in participating.
All else being equal, AHRQ will give
priority to innovators who express a
strong interest in becoming involved in
other activities of the Health Care
Innovations Exchange, such as
participating in learning networks and
providing commentaries.
• AHRQ-funded innovations. The
Health Care Innovations Exchange will
aim to include effective innovations that
are or were funded by the Agency.
Dated: September 18, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–4771 Filed 9–27–07; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Availability of Draft Public Health
Service (PHS) Clinical Practice
Guideline Update on Treating Tobacco
Use and Dependence
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice for pre-publication
review and comment.
AGENCY:
SUMMARY: The Agency for Healthcare
Research and Quality (AHRQ)
announces the availability of a draft
Public Health Service clinical practice
guideline Update on Treating Tobacco
Use and Dependence for pre-publication
review. This PHS guideline update is
being produced by a multidisciplinary
private-sector panel of experts convened
by the agencies of the Public Health
Service. The expert panel will not
respond to individual comments but
will consider all comments in
determining revisions to the guideline.
DATES: Comments must be postmarked
by October 26, 2007.
Request for Draft PHS Guideline
Update
To receive a copy of the draft
guideline update, requests must
include: Requester’s name; Affiliation
(business or organization); Address
(including zip code); Telephone and Fax
numbers. This is a draft document.
Since changes are likely to be made to
the draft guideline update during the
review process this draft document
should not be used as a clinical practice
guideline until final publication. It is
anticipated that the final guideline
update will be made available to the
public in the spring of 2008.
You will be mailed a printed DRAFT
copy of the draft guideline update and
sent by e-mail: (1) An electronic form to
submit any comments and (2) a short
conflict of interest form to be completed
by those submitting comments.
ADDRESSES: Written requests, including
your e-mail address, should be mailed
to: David Fraser, Assistant Director for
Research Administration, University of
Wisconsin-Center for Tobacco Research
and Intervention, 1930 Monroe Street,
Suite 200, Madison, WI 53711–2027.
jlentini on PROD1PC65 with NOTICES
Automated Review Process
A computerized guideline review
process enables comments to be entered
on a special form designed for typed
entry, documentation and consideration
of all comments. The form will be sent
VerDate Aug<31>2005
17:12 Sep 27, 2007
Jkt 211001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
by e-mail, with instructions, to those
requesting the draft guideline update.
To facilitate the review process, it is
strongly recommended that reviewers
use the computer form to record their
comments. For technical assistance or
questions regarding this input process,
please follow the directions in the
materials you receive.
For
information on the PHS Treating
Tobacco Use and Dependence Clinical
Practice Guideline Update, please
contact: CAPT Ernestine Murray, Project
Officer, Agency for Healthcare Research
and Quality (AHRQ), Center for
Outcomes and Evidence, 540 Gaither
Road, Room 6337, Rockville, MD 20850,
Telephone: 301–427–1630, E-mail
Address:
ernestine.murray@ahrq.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In July
2006 a private-sector panel of experts
was convened by the Agencies of the
Public Health Service to update the PHS
Treating Tobacco Use and Dependence
Clinical Practice Guideline to improve
the effectiveness of smoking cessation
activities. A public meeting was also
held in June 2007 for the panel to
receive comments and information
relevant to the update of the PHS
guideline. The panel also reviewed and
synthesized the literature on the topic
and drafted a set of conclusions and
recommendations based on the best
available scientific data and expert
judgments. A draft of these conclusions
and recommendations is now
undergoing peer review by a substantial
number of individuals and groups who
are knowledgeable about clinical
treatment of tobacco dependence.
With this notice, the panel and the
PHS are also making the draft guideline
available to other individuals who wish
to provide written review comments.
After review and evaluation of the
comments received, the panel will make
appropriate revisions to the current
draft PHS guideline update and prepare
the clinical practice guideline update on
Treating Tobacco Use and Dependence.
Potential reviewers should note that the
PHS may disclose the names of the
guideline reviewers at the same time the
guideline is published. The PHS may
also release review comments after the
guideline is published. Generally,
comments will not be attributed to
specific reviewers. However, attribution
may be necessary or useful to indicate
the validity or reliability of particularly
important comments.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 72, Number 188 (Friday, September 28, 2007)]
[Notices]
[Pages 55214-55216]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4771]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
AHRQ Health Care Innovations Exchange
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Submission of Innovations.
-----------------------------------------------------------------------
SUMMARY: To support its objective of accelerating the diffusion and
adoption of innovative health care delivery changes, the Agency for
Healthcare Research and Quality (AHRQ) recently launched version 1.0 of
the AHRQ Health Care Innovations Exchange (HCIE) Web site, https://
www.innovations.ahrq.gov. The HCIE is a new initiative designed to
support health care professionals in sharing and adopting innovations
that improve health care quality. Version 1.0 of the Web site is
focused on stimulating creativity and innovation and will serve as a
virtual place to which innovators will be encouraged to submit their
innovations and experiences from which potential adopters can begin
learning about the nuances of implementation.
In Spring 2008, AHRQ will deploy version 2.0 of its Health Care
Innovations Exchange site making hundreds of profiles of health care
service innovations of varying degrees of novelty and scientific rigor
accessible to the public. Version 2.0 will also offer expert
commentary; stories; tools; lessons learned; ``change packages''--sets
of innovations implemented simultaneously; expanded content on
implementation; and opportunities to learn and network.
To build the database of innovations profiles, AHRQ invites
submissions of
[[Page 55215]]
health service innovations to its Health Care Innovations Exchange. The
AHRQ Health Care Innovations Exchange database will cover the broad
spectrum of health care settings, systems, and providers. Public health
priority diseases/conditions, priority populations, and efforts to
reduce disparities in quality will be highlighted.
The AHRQ Health Care Innovations Exchange is seeking a broad range
of novel health care strategies, activities, and tools. AHRQ invites
participation in its Health Care Innovations Exchange by submitting
descriptions of innovative efforts to improve the delivery of health
care services.
DATES: There is no deadline for submission. It is a continuous
submission and review process.
Special Incentive To Submit
AHRQ will provide early submitters (those who submit by January 15,
2008) and opportunity to preview and comment on version 2.0 of the
Health Care Innovations Exchange Web site via a secure mechanism. In
this preview, an opportunity will be given to browse and search the
innovations profiled up to that point.
ADDRESSES: Submit to info@innovations.ahrq.gov.
How To Submit
To submit a health care innovation for possible posting, send a
description of the innovation that would include the health care
setting and patient population it is our could be used for and any
results that have been documented, to the Health Care Innovations
Exchange at info@innovations.ahrq.gov. Please use the words
``Innovation Submission'' in the subject line. If you prefer, you can
fax information about your innovation to 301-610-4950. You may also
mail information to Mary Nix, Agency for Healthcare Research and
Quality, Center for Outcomes and Evidence, 540 Gaither Road, Rockville,
MD 20850. Detailed information on submitting can be obtained from the
AHRQ Health Care Innovations Exchange Web page titled ``Share Your
Innovations'', https://www.innovations.ahrq.gov/share/share.aspx.
Supporting documents may be sent with the submission. Once AHRQ has
reviewed your submission and identified it as a priority item for
posting, AHRQ will contact the submitter to discuss the details
regarding what will be included in standardized postings. Copyright or
other intellectual property issues, if any, will be addressed at that
time.
If the innovation is accepted for inclusion, AHRQ will develop a
detailed profile and send it to the submitter to review for accuracy
and completeness. The innovation will then be ready for publication in
Version 2.0 of the Health Care Innovations Exchange scheduled for
public release in Spring 2008.
FOR FURTHER INFORMATION CONTACT: Explore: https://www.innovations.
ahrq.gov; And/Or Contact: Mary P. Nix, MS, MT(ASCP)SBB, Health
Scientist Administrator, Agency for Healthcare Research and Quality,
540 Gaither Road, Rockville, MD 20850, phone: 301-427-1624, e-mail:
Mary.Nix@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Inclusion Criteria
To be considered for inclusion, health are innovations have to meet
six criteria with respect to the nature of the activity, the level of
documentation, and the participation of the innovator. These are
minimum requirements. The ultimate decision to publish a detailed
profile of an innovation (an Innovation Profile) will depend on several
factors, including an evaluation by AHRQ, AHRQ's priorities (see
below), and the number of similar ideas in the Health Care Innovations
Exchange. Innovations that do not qualify for an Innovation Profile may
qualify as Innovation Briefs (short descriptions of intriguing
activities that either do not meet the minimum requirements or are not
regarded as high priority) or Innovation Attempts (descriptions of
projects that did not succeed as planned). Criteria to be considered
are:
The innovation is a patient care services activity
The innovation does not have to involve direct patient care or
direct contact with health care consumers. However, it must have
important implications for the delivery of patient care--whether
preventative, emergent, chronic, acute, rehabilitative, long-term, or
end-of-life. Innovations that are devices, tools, technology, software,
curricula, policies, procedures, and changes to the physical
environment will generally be excluded unless they are tied to a
specific and associated change in the health care delivery process when
implemented.
The innovation intends to improve one or more domains of health care
quality
The innovation must be designed to address one or more specific
measurable indicators of quality in one or more of the following
domains: effectiveness, efficiency, equity, patient-centeredness,
safety, and timeliness. The measurable quality indicators do not have
to come from an established measure set, but they must be clearly
defined and relevant to the quality issue the innovation addresses. In
addition, the innovation must not contradict established standards of
evidence-based care.
There is reason to believe that the innovation will be effective
Evidence that the innovation is likely to achieve its goals must be
provided. Ideally, quantitative or qualitative support for a link
between the innovation and improved performance on the defined quality
indicator should be offered. However, if data are unavailable, limited,
or lacking methodological rigor, the design or theoretical foundation
of the innovative activity may serve as sufficient support.
The activity is truly innovative in a given context
For the purposes of the Health Care Innovation Exchange,
innovations are activities that are generally perceived as new in a
particular context or setting relative to the usual care processes. In
addition to brand new ideas, this includes activities adapted from
other industries to health care, transferred from one health care
setting or market segment to another, drawn from settings in other
countries, or applied to a new or different patient population. A
description of how the innovation differs from what was regarded as
standard practice in the setting in which it was implemented must be
supplied.
Information about the innovation is publicly available
Innovators must be willing to make enough information freely
available to enable a user of the Health Care Innovations Exchange to
understand the elements of the innovation and, if desired, adopt the
innovation. This requirement does not exclude innovations that
incorporate commercial products or other materials for which there may
be a fee or licensing requirements. It is not necessary for all
information about the innovation to be publicly available, but AHRQ
will need access to information with sufficient detail to produce a
full profile.
The innovator (or a representative) is willing and able to participate
in the Health Care Innovations Exchange
A knowledgeable contact person must be available as a resource for
potential adopters of the innovation for at least one year. To minimize
the burden on innovators, the Health Care Innovations
[[Page 55216]]
Exchange staff will facilitate communication among users and developers
of innovations. However, the participation of the innovator is
essential to the ability of the Health Care Innovations Exchange to
foster and promote the diffusion of innovations through social
learning, a central goal of this program. The level of participation
can vary according to innovator interest and schedules. Innovators will
be expected to respond to occasional inquiries and to join a Health
Care Innovations Exchange community of practice related to the
innovator's particular innovation, so that ideas can be shared in an
organized instructional fashion or setting.
AHRQ's Priorities
Specific populations. AHRQ is interested in identifying
innovations that will help to reduce disparities in health care and
health status. Populations of interest to AHRQ are low-income groups,
minority groups, women, children, the elderly, and individuals with
special health care needs.
Potential for high impact. The Health Care Innovations
Exchange will give publication or dissemination priority to innovations
that are likely to have a significant effect on the overall value of
health care. Impact may be defined in different ways, e.g., the
innovation may affect a broad population, address a critical health
issue, or demonstrate large cost savings.
Innovator interest in participating. All else being equal,
AHRQ will give priority to innovators who express a strong interest in
becoming involved in other activities of the Health Care Innovations
Exchange, such as participating in learning networks and providing
commentaries.
AHRQ-funded innovations. The Health Care Innovations
Exchange will aim to include effective innovations that are or were
funded by the Agency.
Dated: September 18, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-4771 Filed 9-27-07; 8:45 am]
BILLING CODE 4160-90-M
